Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Celiac Disease Monocytes Induce a Barrier Defect in Intestinal Epithelial Cells.

Delbue D, Cardoso-Silva D, Branchi F, Itzlinger A, Letizia M, Siegmund B, Schumann M.

Int J Mol Sci. 2019 Nov 9;20(22). pii: E5597. doi: 10.3390/ijms20225597.

2.

Intestinal Barrier Function in Gluten-Related Disorders.

Cardoso-Silva D, Delbue D, Itzlinger A, Moerkens R, Withoff S, Branchi F, Schumann M.

Nutrients. 2019 Oct 1;11(10). pii: E2325. doi: 10.3390/nu11102325. Review.

3.

11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.

Lemos LG, Nestal de Moraes G, Delbue D, Vasconcelos Fda C, Bernardo PS, Lam EW, Buarque CD, Costa PR, Maia RC.

J Cancer Res Clin Oncol. 2016 Oct;142(10):2119-30. doi: 10.1007/s00432-016-2212-6. Epub 2016 Aug 12.

4.

FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.

Nestal de Moraes G, Delbue D, Silva KL, Robaina MC, Khongkow P, Gomes AR, Zona S, Crocamo S, Mencalha AL, Magalhães LM, Lam EW, Maia RC.

Cell Signal. 2015 Dec;27(12):2496-505. doi: 10.1016/j.cellsig.2015.09.013. Epub 2015 Sep 25.

PMID:
26404623
5.

Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.

Nestal de Moraes G, Vasconcelos FC, Delbue D, Mognol GP, Sternberg C, Viola JP, Maia RC.

Eur J Cell Biol. 2013 Aug-Sep;92(8-9):247-56. doi: 10.1016/j.ejcb.2013.08.001. Epub 2013 Aug 31.

PMID:
24064045

Supplemental Content

Loading ...
Support Center